155 related articles for article (PubMed ID: 3904387)
1. Electropharmacologic testing in sustained ventricular tachycardia associated with coronary heart disease: value of the response to intravenous procainamide in predicting the response to oral procainamide and oral quinidine treatment.
Oseran DS; Gang ES; Rosenthal ME; Mandel WJ; Peter T
Am J Cardiol; 1985 Nov; 56(13):883-6. PubMed ID: 3904387
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of the response to intravenous procainamide during electrophysiologic study in predicting the response to oral quinidine in patients with inducible sustained monomorphic ventricular tachycardia associated with coronary artery disease.
Pires LA; Wagshal AB; Greene TO; Mittleman RS; Huang SK
Am J Cardiol; 1993 Oct; 72(12):908-10. PubMed ID: 8105674
[TBL] [Abstract][Full Text] [Related]
3. Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens.
Horowitz LN; Josephson ME; Farshidi A; Spielman SR; Michelson EL; Greenspan AM
Circulation; 1978 Dec; 58(6):986-97. PubMed ID: 709782
[TBL] [Abstract][Full Text] [Related]
4. The role of combination therapy with mexiletine and procainamide in patients with inducible sustained ventricular tachycardia refractory to intravenous procainamide.
Widerhorn J; Sager PT; Rahimtoola SH; Bhandari AK
Pacing Clin Electrophysiol; 1991 Mar; 14(3):420-6. PubMed ID: 1708872
[TBL] [Abstract][Full Text] [Related]
5. Paired comparisons of efficacy of intravenous and oral procainamide in patients with inducible sustained ventricular tachyarrhythmias.
Interian A; Zaman L; Velez-Robinson E; Kozlovskis P; Castellanos A; Myerburg RJ
J Am Coll Cardiol; 1991 Jun; 17(7):1581-6. PubMed ID: 2033190
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of the electrophysiology laboratory for evaluation of proarrhythmic drug response in coronary artery disease.
Buxton AE; Rosenthal ME; Marchlinski FE; Miller JM; Flores B; Josephson ME
Am J Cardiol; 1991 Apr; 67(9):835-42. PubMed ID: 1707220
[TBL] [Abstract][Full Text] [Related]
7. Comparative electrophysiologic effects of intravenous and oral procainamide in patients with sustained ventricular arrhythmias.
Marchlinski FE; Buxton AE; Vassallo JA; Waxman HL; Cassidy DM; Doherty JU; Josephson ME
J Am Coll Cardiol; 1984 Dec; 4(6):1247-54. PubMed ID: 6209319
[TBL] [Abstract][Full Text] [Related]
8. The role of beta-blockade therapy for ventricular tachycardia induced with isoproterenol: a prospective analysis.
DiCarlo LA; Susser F; Winston SA
Am Heart J; 1990 Dec; 120(6 Pt 1):1347-55. PubMed ID: 1978977
[TBL] [Abstract][Full Text] [Related]
9. Electropharmacologic effect of a standard dose of intravenous procainamide in patients with sustained ventricular tachycardia.
Rials SJ; Britchkow D; Marinchak RA; Kowey PR
Clin Cardiol; 2000 Mar; 23(3):171-4. PubMed ID: 10761804
[TBL] [Abstract][Full Text] [Related]
10. Electrophysiologic evaluation of the antiarrhythmic effects of N-acetylprocainamide for ventricular tachycardia secondary to coronary artery disease.
Wynn J; Miura DS; Torres V; Flowers D; Keefe D; Williams S; Somberg JC
Am J Cardiol; 1985 Nov; 56(13):877-81. PubMed ID: 2414983
[TBL] [Abstract][Full Text] [Related]
11. Electrophysiologic and clinical factors influencing response to class IA antiarrhythmic agents in patients with inducible sustained monomorphic ventricular tachycardia.
Gold RL; Haffajee CI; Alpert JS
Am Heart J; 1986 Jul; 112(1):9-13. PubMed ID: 3728294
[TBL] [Abstract][Full Text] [Related]
12. Enhanced efficacy of oral sotalol for sustained ventricular tachycardia refractory to type I antiarrhythmic drugs.
Kienzle MG; Martins JB; Wendt DJ; Constantin L; Hopson R; McCue ML
Am J Cardiol; 1988 May; 61(13):1012-7. PubMed ID: 3129926
[TBL] [Abstract][Full Text] [Related]
13. Amiodarone versus amiodarone and a type IA agent for treatment of patients with rapid ventricular tachycardia.
Marchlinski FE; Buxton AE; Miller JM; Vassallo JA; Flores BT; Josephson ME
Circulation; 1986 Nov; 74(5):1037-43. PubMed ID: 3769163
[TBL] [Abstract][Full Text] [Related]
14. Limitations of failure of procainamide during electrophysiologic testing to predict response to other medical therapy.
Rae AP; Sokoloff NM; Webb CR; Spielman SR; Greenspan AM; Horowitz LN
J Am Coll Cardiol; 1985 Aug; 6(2):410-6. PubMed ID: 4019928
[TBL] [Abstract][Full Text] [Related]
15. Effects of intravenous disopyramide and quinidine on normal myocardium and on the characteristics of arrhythmias: intraindividual comparison in patients with sustained ventricular tachycardia.
Rizos I; Brachmann J; Lengfelder W; Schmitt C; von Olshausen K; Kübler W; Senges J
Eur Heart J; 1987 Feb; 8(2):154-63. PubMed ID: 3569310
[TBL] [Abstract][Full Text] [Related]
16. Effects of incremental doses of procainamide on ventricular refractoriness, intraventricular conduction, and induction of ventricular tachycardia.
Morady F; DiCarlo LA; de Buitleir M; Krol RB; Baerman JM; Kou WH
Circulation; 1986 Dec; 74(6):1355-64. PubMed ID: 2430731
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of combination therapy with mexiletine and a type IA agent for inducible ventricular tachyarrhythmias secondary to coronary artery disease.
Greenspan AM; Spielman SR; Webb CR; Sokoloff NM; Rae AP; Horowitz LN
Am J Cardiol; 1985 Aug; 56(4):277-84. PubMed ID: 4025166
[TBL] [Abstract][Full Text] [Related]
18. Intravenous quinidine: relations among concentration, tachyarrhythmia suppression and electrophysiologic actions with inducible sustained ventricular tachycardia.
Duff HJ; Wyse DG; Manyari D; Mitchell LB
Am J Cardiol; 1985 Jan; 55(1):92-7. PubMed ID: 3966404
[TBL] [Abstract][Full Text] [Related]
19. Prospective comparison of intravenous quinidine and intravenous procainamide in patients undergoing electrophysiologic testing.
Holzberger PT; Greenberg ML; Paicopolis MC; Ozahowski TP; Ho PC; O'Connor GT
Am Heart J; 1998 Jul; 136(1):49-56. PubMed ID: 9665218
[TBL] [Abstract][Full Text] [Related]
20. Coronary venous retroinfusion of procainamide: a new approach for the management of spontaneous and inducible sustained ventricular tachycardia during myocardial infarction.
Karagueuzian HS; Ohta M; Drury JK; Fishbein MC; Meerbaum S; Corday E; Mandel WJ; Peter T
J Am Coll Cardiol; 1986 Mar; 7(3):551-63. PubMed ID: 3950235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
